Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


Articles published in Br J Psychiatry

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    March 2024
  1. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    PubMed    


    February 2024
  2. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    PubMed    


    January 2024
  3. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    PubMed     Abstract available


    November 2023
  4. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


    October 2023
  5. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


  6. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


  7. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    PubMed     Abstract available


    August 2023
  8. JIN H, Kolawole O, Wang Z
    Cost-effectiveness analysis of physical activity interventions for people with schizophrenia or bipolar disorder: systematic review.
    Br J Psychiatry. 2023;223:362-376.
    PubMed     Abstract available


  9. KELLEHER I
    Author's Reply. RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394-395.
    PubMed    


  10. GRIFFITHS SL, Brown L, Kirkbride JB
    RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394.
    PubMed    


    July 2023
  11. FERNANDEZ-EGEA E, Mucci A, Lee J, Kirkpatrick B, et al
    A new era for the negative symptoms of schizophrenia.
    Br J Psychiatry. 2023;223:269-270.
    PubMed     Abstract available


  12. AYMERICH C, Catalan A, Salazar de Pablo G
    RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336.
    PubMed    


  13. KIRKPATRICK B, Luther L, Strauss GP
    Negative symptoms in the clinic: we treat what we can describe.
    Br J Psychiatry. 2023;223:271-272.
    PubMed     Abstract available


  14. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336-337.
    PubMed    


  15. CHEN EYH, Wong SMY, Hui CLM, Suen YN, et al
    The emergence of primary negative symptoms: relevance of timing?
    Br J Psychiatry. 2023;223:280-281.
    PubMed     Abstract available


    June 2023
  16. HOWES O, Fusar-Poli P, Osugo M
    Treating negative symptoms of schizophrenia: current approaches and future perspectives.
    Br J Psychiatry. 2023 Jun 5:1-4. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


  17. BYNG R, Creanor S, Jones B, Hosking J, et al
    The effectiveness of a primary care-based collaborative care model to improve quality of life in people with severe mental illness: PARTNERS2 cluster randomised controlled trial.
    Br J Psychiatry. 2023;222:246-256.
    PubMed     Abstract available


  18. NORTHWOOD K, Pearson E, Arnautovska U, Kisely S, et al
    Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis.
    Br J Psychiatry. 2023;222:241-245.
    PubMed     Abstract available


    May 2023
  19. GALDERISI S, Kaiser S
    The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges.
    Br J Psychiatry. 2023 May 26:1-3. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


  20. PENADES R, Wykes T
    Use of cognitive remediation to treat negative symptoms in schizophrenia: is it time yet?
    Br J Psychiatry. 2023 May 17:1-2. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


  21. SALAZAR DE PABLO G, Catalan A, Vaquerizo Serrano J, Pedruzo B, et al
    Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Br J Psychiatry. 2023 May 17:1-13. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    March 2023
  22. CELLA M, Roberts S, Pillny M, Riehle M, et al
    Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses.
    Br J Psychiatry. 2023 Mar 15:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available


    January 2023
  23. KELLEHER I
    Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023 Jan 12:1-3. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


  24. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023 Jan 10:1-3. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


  25. O'BRIEN KJ, Ered A, Korenic SA, Olino TM, et al
    Childhood trauma, perceived stress and anhedonia in individuals at clinical high risk for psychosis: multigroup mediation analysis.
    Br J Psychiatry. 2023 Jan 5:1-7. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    December 2022
  26. AHANGARI M, Bustamante D, Kirkpatrick R, Nguyen TH, et al
    Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.
    Br J Psychiatry. 2022 Dec 12:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


  27. IKKOS G, Stanghellini G
    Sensibility and schizophrenia: Wilhelm Waiblinger on Friedrich Holderlin's life, poetry and madness - psychiatry in literature.
    Br J Psychiatry. 2022;221:739.
    PubMed    


  28. BUTLER E, Pillinger T, Brown K, Borgan F, et al
    Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study.
    Br J Psychiatry. 2022;221:740-747.
    PubMed     Abstract available


    November 2022
  29. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis - CORRIGENDUM.
    Br J Psychiatry. 2022 Nov 14:1. doi: 10.1192/bjp.2022.
    PubMed    


    September 2022
  30. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis.
    Br J Psychiatry. 2022 Sep 23:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    August 2022
  31. LAHTEENVUO M, Luykx JJ, Taipale H, Mittendorfer-Rutz E, et al
    Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.
    Br J Psychiatry. 2022 Aug 25:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    July 2022
  32. FLEETWOOD K, Wild SH, Smith DJ, Mercer SW, et al
    Association of severe mental illness with stroke outcomes and process-of-care quality indicators: nationwide cohort study.
    Br J Psychiatry. 2022;221:394-401.
    PubMed     Abstract available


    May 2022
  33. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
    Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.
    PubMed    


    April 2022
  34. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make?
    Br J Psychiatry. 2022 Apr 6:1-3. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    February 2022
  35. ANTONUCCI LA, Penzel N, Sanfelici R, Pigoni A, et al
    Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.
    Br J Psychiatry. 2022 Feb 14:1-17. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


  36. CUI Y, Li C, Liu B, Sui J, et al
    Consistent brain structural abnormalities and multisite individualised classification of schizophrenia using deep neural networks.
    Br J Psychiatry. 2022 Feb 11:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    January 2022
  37. LEE R, Leighton SP, Thomas L, Gkoutos GV, et al
    Prediction models in first-episode psychosis: systematic review and critical appraisal.
    Br J Psychiatry. 2022 Jan 24:1-13. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    December 2021
  38. XI YB, Wu XS, Cui LB, Bai LJ, et al
    Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication.
    Br J Psychiatry. 2021 Dec 2:1-8. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


  39. BAKER SJ, Jackson M, Jongsma H, Saville CWN, et al
    The ethnic density effect in psychosis: a systematic review and multilevel meta-analysis.
    Br J Psychiatry. 2021;219:632-643.
    PubMed     Abstract available


  40. BHUI K, Halvorsrud K, Mooney R, Hosang GM, et al
    Is psychosis a syndemic manifestation of historical and contemporary adversity? Findings from UK Biobank.
    Br J Psychiatry. 2021;219:686-694.
    PubMed     Abstract available


  41. ELLETT L, Chadwick P
    Recommendations for monitoring and reporting harm in mindfulness for psychosis research.
    Br J Psychiatry. 2021;219:629-631.
    PubMed     Abstract available


    July 2021
  42. MCDONALD K, Ding T, Ker H, Dliwayo TR, et al
    Using epidemiological evidence to forecast population need for early treatment programmes in mental health: a generalisable Bayesian prediction methodology applied to and validated for first-episode psychosis in England.
    Br J Psychiatry. 2021;219:383-391.
    PubMed     Abstract available


  43. VAN DER MEER L, Kaiser S, Castelein S
    Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials.
    Br J Psychiatry. 2021;219:359-360.
    PubMed     Abstract available


  44. CASTELEIN S, Timmerman ME, van der Gaag M, Visser E, et al
    Clinical, societal and personal recovery in schizophrenia spectrum disorders across time: states and annual transitions.
    Br J Psychiatry. 2021;219:401-408.
    PubMed     Abstract available


  45. ZHU Y, Wang S, Gong X, Edmiston EK, et al
    Associations between hemispheric asymmetry and schizophrenia-related risk genes in people with schizophrenia and people at a genetic high risk of schizophrenia.
    Br J Psychiatry. 2021;219:392-400.
    PubMed     Abstract available


  46. BHATTACHERJEE S, Young A, Ahuja N, Allen S, et al
    Should intramuscular clozapine be adopted into mainstream clinical practice?
    Br J Psychiatry. 2021;219:357-358.
    PubMed     Abstract available


    May 2021
  47. SISKIND D, Orr S, Sinha S, Yu O, et al
    Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Br J Psychiatry. 2021 May 11:1-6. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    October 2020
  48. FOND G, Pauly V, Bege T, Orleans V, et al
    Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database.
    Br J Psychiatry. 2020;217:568-574.
    PubMed     Abstract available


    May 2020
  49. OHI K, Shimada T, Kataoka Y, Yasuyama T, et al
    Genetic correlations between subcortical brain volumes and psychiatric disorders.
    Br J Psychiatry. 2020;216:280-283.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.